TIL Instil Bio, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 13, 2026
$7.22
· of 52w range
· above low
· to high
$5.6752w low
$21.9852w high
Market Cap (MRQ)
$49M
P/E
-0.7
EPS
$-10.70
your badges
52W Range
$6–$22
Analyst Rating
BUY
Price Target
$7
P/E
-0.7
ROE
-58.1%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
TIL Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$7.22
Market Cap (MRQ)
$49M
P/E
-0.7
EPS
$-10.70
ROE
-58.1%
52W Range
$6–$22
TIL Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Dec. 8, 2023 | 1-for-20 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue·2020-12-31 → 2021-12-31
EPS$-10.702020-12-31 → 2025-12-31
Free Cash Flow·2021-12-31 → 2024-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | TIL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.75Y avg ≈-46.9 | ≈-46.9 | · | · | |
| P/S | 941.75Y avg ≈9075.7 | ≈9075.7 | · | · | |
| P/B (MRQ) | 0.55Y avg ≈17.1 | ≈17.1 | · | · | |
| Price / Cash Flow | -1.35Y avg ≈-75.1 | ≈-75.1 | · | · | |
| Price / Tangible Book | 0.45Y avg ≈17.3 | ≈17.3 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | TIL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -30.6%5Y avg ≈-33.8% | ≈-33.8% | -86.2% | Top tier | |
| ROE | -58.1%5Y avg ≈-50.7% | ≈-50.7% | -111.1% | Top tier | |
| ROIC | -69.0%5Y avg ≈-57.3% | ≈-57.3% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | TIL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 21.75Y avg ≈18.0 | ≈18.0 | 2.5 | Strong liquidity | |
| Quick Ratio | 1.45Y avg ≈7.1 | ≈7.1 | 1.8 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-6.0%
Next Report
Nov 11, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 11, 2026 | $-0.63 | $-0.43 | -45.1% |
| March 31, 2026 | May 15, 2026 | $-0.62 | $-0.60 | -4.0% |
| Dec. 31, 2025 | $-1.21 | $-2.05 | 40.9% | |
| Sept. 30, 2025 | $-2.01 | $-2.38 | 15.5% | |
| June 30, 2025 | $-3.24 | $-2.53 | -28.2% | |
| March 31, 2025 | $-4.32 | $-2.61 | -65.3% | |
| Dec. 31, 2024 | $-1.82 | $-3.25 | 44.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | $0 | $138.0K | |
| R&D Expense | · | · | $40M | $141M | $107M | $19M | |
| SG&A Expense | $27M | $44M | $48M | $62M | $48M | $14M | |
| Operating Expenses | $79M | $74M | $159M | $226M | $156M | $34M | |
| Operating Income | $-79M | $-74M | $-159M | $-226M | $-156M | $-34M | |
| Interest Expense | · | · | $5M | $2M | $0 | · | |
| Other Non-op | $212.0K | $-3M | $-575.0K | $-564.0K | $-1M | $-4M | |
| Pretax Income | $-71M | $-74M | $-156M | $-225M | $-157M | $-38M | |
| Income Tax | $0 | · | $0 | $-2M | $39.0K | $151.0K | |
| Net Income | $-71M | $-74M | $-156M | $-223M | $-157M | $-38M | |
| EPS (Basic) | $-10.70 | $-11.39 | $-24.00 | $-34.46 | $-1.48 | $-2.36 | |
| EPS (Diluted) | $-10.70 | $-11.39 | $-24.00 | $-34.46 | $-1.48 | $-2.36 | |
| Shares (Basic) | 6,668,268 | 6,510,138 | 6,503,913 | 6,475,631 | 105,993,230 | 15,997,794 | |
| Shares (Diluted) | 6,668,268 | 6,510,138 | 6,503,913 | 6,475,631 | 105,993,230 | 15,997,794 | |
| EBITDA | $-78M | $-70M | $-154M | $-220M | $-153M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $9M | $9M | $44M | $38M | $242M | |
| Short-term Investments | · | · | $141M | $217M | $417M | $0 | |
| Prepaid Expense | $3M | $9M | $9M | $8M | $10M | $4M | |
| Other Current Assets | $148.0K | $959.0K | $3M | · | · | $70.0K | |
| Current Assets | $191M | $124M | $161M | $269M | $464M | $246M | |
| PP&E (Net) | $126.0K | $129M | $139M | $197M | $122M | $55M | |
| PP&E (Gross) | $509.0K | $134M | $146M | $205M | $125M | $56M | |
| Accum. Depreciation | $383.0K | $5M | $8M | $8M | $3M | $306.0K | |
| Goodwill | · | · | · | $0 | $6M | $6M | |
| Other Non-current Assets | $4M | $4M | $639.0K | $3M | $8M | $2M | |
| Total Assets | $204M | $264M | $326M | $482M | $610M | $319M | |
| Accounts Payable | $779.0K | $659.0K | $1M | $2M | $6M | $3M | |
| Current Liabilities | $5M | $8M | $11M | $33M | $41M | $13M | |
| Capital Leases | $0 | $1M | $3M | $5M | $0 | · | |
| Deferred Tax | · | · | · | $0 | $2M | $2M | |
| Other Non-current Liabilities | $8.0K | $83.0K | $80.0K | $332.0K | $20.0K | $0 | |
| Total Liabilities | $90M | $94M | $100M | $119M | $55M | $27M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $841M | $825M | $807M | $789M | $757M | $6M | |
| Retained Earnings | $-726M | $-655M | $-581M | $-425M | $-202M | $-45M | |
| AOCI | $-583.0K | $-228.0K | $-348.0K | $-493.0K | $-87.0K | $-283.0K | |
| Stockholders' Equity | $114M | $169M | $226M | $364M | $555M | $-40M | |
| Liabilities + Equity | $204M | $264M | $326M | $482M | $610M | $319M | |
| Shares Outstanding | 6,781,976 | 6,525,887 | 6,503,913 | 6,503,913 | 6,451,463 | 20,591,554 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $534.0K | $4M | $5M | $6M | $3M | $256.0K | |
| Stock-based Comp | $9M | $17M | $18M | $30M | $26M | $2M | |
| Deferred Tax | · | · | $0 | $-2M | $39.0K | $267.0K | |
| Other Non-cash | $26M | $-2M | $51M | $9M | $6M | · | |
| Operating Cash Flow | $-37M | $-56M | $-82M | $-180M | $-122M | $-30M | |
| CapEx | · | $0 | $21M | $85M | $58M | $51M | |
| Investing Cash Flow | $25M | $54M | $41M | $115M | $-474M | $-51M | |
| Stock Issued | $7M | $0 | · | · | · | · | |
| Net Stock Activity | $7M | · | · | · | · | · | |
| Financing Cash Flow | $7M | $2M | $8M | $72M | $393M | $313M | |
| Free Cash Flow | · | $-56M | $-103M | $-265M | $-180M | · | |
| Levered FCF | · | · | $-108M | $-267M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -30.6% | -25.2% | -38.6% | -40.9% | -33.8% | · | |
| ROE | -58.1% | -42.9% | -67.9% | -57.6% | -27.1% | · | |
| ROIC | -69.0% | · | -70.5% | -61.7% | -28.0% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 39.5 | 15.8 | 15.2 | 8.2 | 11.2 | · | |
| Quick Ratio | 1.4 | 1.1 | 14.2 | 8.0 | 11.0 | · | |
| Interest Coverage | · | · | -30.6 | -120.3 | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.0 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $16.79 | $25.96 | $34.72 | $2.80 | $4.30 | · | |
| Revenue / Share | · | · | · | · | $0.00 | · | |
| Cash Flow / Share | $-5.49 | $-8.56 | $-12.61 | $-1.39 | $-1.15 | · | |
| Cash / Share | $0.98 | $1.35 | $1.41 | $0.34 | $0.29 | · | |
| EPS (TTM) | $-10.70 | $-11.39 | $-24.00 | $-34.46 | $-1.48 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $52.0K | $52.0K | $52.0K | $52.0K | $0 | · | |
| Net Income TTM | $-71M | $-74M | $-156M | $-223M | $-157M | · | |
| Market Cap | $75M | $125M | $50M | $1.64B | $44.15B | · | |
| P/E | -1.0 | -1.7 | -0.3 | -0.4 | -231.2 | · | |
| P/S | 1434.6 | 2395.8 | 953.1 | 31519.2 | · | · | |
| P/B | 0.7 | 0.7 | 0.2 | 4.5 | 79.5 | · | |
| P / Tangible Book | 0.7 | 0.7 | 0.2 | 4.5 | 80.4 | · | |
| P / Cash Flow | -2.0 | -2.2 | -0.6 | -9.1 | -361.5 | · | |
| P / FCF | · | -2.2 | -0.5 | -6.2 | -245.3 | · | |
| Earnings Yield | -97.3% | -59.7% | -315.0% | -273.5% | -0.43% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | · | · | · | · | · | $3M | $7M | · | $8M | $8M | $21M | $21M | $40M | |
| SG&A Expense | $5M | $5M | $6M | $6M | $6M | $9M | $10M | $11M | $11M | $12M | $11M | $12M | $12M | $13M | $13M | $17M | |
| Operating Expenses | $6M | $7M | $10M | $15M | $23M | $31M | $12M | $24M | $14M | $24M | $13M | $67M | $21M | $58M | $57M | $57M | |
| Operating Income | $-6M | $-7M | $-10M | $-15M | $-23M | $-31M | $-12M | $-24M | $-14M | $-24M | $-13M | $-67M | $-21M | $-58M | $-57M | $-57M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $2M | · | $2M | $590.0K | $636.0K | $745.0K | $807.0K | |
| Other Non-op | $-10.0K | $-182.0K | $-55.0K | $-118.0K | $342.0K | $43.0K | $-1M | $-530.0K | $-702.0K | $-428.0K | $-120.0K | $-1M | $628.0K | $-57.0K | $1M | $-415.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-13M | $-67M | $-19M | $-57M | $-54M | $-57M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-605.0K | $-371.0K | |
| Net Income | $-4M | $-4M | $-8M | $-14M | $-21M | $-28M | $-12M | $-23M | $-15M | $-24M | $-13M | $-67M | $-19M | $-57M | $-54M | $-56M | |
| EPS (Basic) | $-0.63 | $-0.62 | $-1.13 | $-2.01 | $-3.24 | $-4.32 | $-1.82 | $-3.54 | $-2.29 | $-3.74 | $-1.99 | $-10.37 | $-2.87 | $-8.77 | $-33.15 | $-0.43 | |
| EPS (Diluted) | $-0.63 | $-0.62 | $-1.13 | $-2.01 | $-3.24 | $-4.32 | $-1.82 | $-3.54 | $-2.29 | $-3.74 | $-1.99 | $-10.37 | $-2.87 | $-8.77 | $-33.15 | $-0.43 | |
| Shares (Basic) | 6,781,976 | 6,781,976 | · | 6,757,742 | 6,596,975 | 6,532,658 | · | 6,506,681 | 6,503,913 | 6,503,913 | · | 6,503,913 | 6,503,913 | 6,503,913 | · | 129,680,217 | |
| Shares (Diluted) | 6,781,976 | 6,781,976 | · | 6,757,742 | 6,596,975 | 6,532,658 | · | 6,506,681 | 6,503,913 | 6,503,913 | · | 6,503,913 | 6,503,913 | 6,503,913 | · | 129,680,217 | |
| EBITDA | $-6M | $-7M | · | $-15M | $-23M | $-30M | · | $-24M | $-14M | $-23M | · | $-67M | $-21M | $-57M | · | $-57M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $5M | $7M | $6M | $8M | $15M | $9M | $7M | $7M | $5M | $9M | $9M | $22M | $27M | $44M | $41M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $174M | $180M | $196M | $217M | $262M | |
| Prepaid Expense | $2M | $2M | $3M | $4M | $3M | $3M | $9M | $12M | $6M | $6M | $9M | $11M | $12M | $9M | $8M | $10M | |
| Other Current Assets | $76.0K | $143.0K | $148.0K | $164.0K | $154.0K | $192.0K | $959.0K | $2M | · | · | $3M | · | · | · | · | · | |
| Current Assets | $72M | $188M | $191M | $196M | $207M | $219M | $124M | $133M | $155M | $161M | $161M | $196M | $221M | $240M | $269M | $314M | |
| PP&E (Net) | $112M | $112.0K | $126.0K | $138.0K | $150.0K | $162.0K | $129M | $130M | $133M | $134M | $139M | $139M | $181M | $180M | $197M | $185M | |
| PP&E (Gross) | $112M | · | $509.0K | $509.0K | $509.0K | $509.0K | $134M | $134M | $138M | $138M | $146M | $146M | $187M | $185M | $205M | $191M | |
| Accum. Depreciation | $638.0K | $389.0K | $383.0K | $371.0K | $359.0K | $347.0K | $5M | $4M | $5M | $4M | $8M | $6M | $6M | $5M | $8M | $6M | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6M | |
| Other Non-current Assets | $4M | $4M | $4M | $4M | $11M | $10M | $4M | $6M | $581.0K | $2M | $639.0K | $3M | $3M | $4M | $3M | $5M | |
| Total Assets | $198M | $200M | $204M | $212M | $231M | $237M | $264M | $273M | $294M | $306M | $326M | $340M | $408M | $427M | $482M | $533M | |
| Accounts Payable | $795.0K | $793.0K | $779.0K | $928.0K | $523.0K | $286.0K | $659.0K | $1M | $1M | $1M | $1M | $2M | $2M | $1M | $2M | $5M | |
| Current Liabilities | $3M | $5M | $5M | $6M | $14M | $7M | $8M | $10M | $10M | $11M | $11M | $13M | $18M | $27M | $33M | $42M | |
| Capital Leases | $2M | · | $0 | $0 | $6.0K | $48.0K | $1M | $1M | $2M | $2M | $3M | $3M | $4M | $4M | $5M | $6M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $555.0K | |
| Other Non-current Liabilities | $0 | $8.0K | $8.0K | $88.0K | $90.0K | $85.0K | $83.0K | $8.0K | $8.0K | $43.0K | $80.0K | $115.0K | $162.0K | $196.0K | $332.0K | $375.0K | |
| Total Liabilities | $90M | $90M | $90M | $91M | $99M | $93M | $94M | $96M | $99M | $100M | $100M | $106M | $112M | $116M | $119M | $122M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $843M | $842M | $841M | $839M | $837M | $829M | $825M | $820M | $816M | $812M | $807M | $803M | $798M | $794M | $789M | $782M | |
| Retained Earnings | $-735M | $-731M | $-726M | $-718M | $-705M | $-683M | $-655M | $-643M | $-620M | $-605M | $-581M | $-568M | $-501M | $-482M | $-425M | $-371M | |
| AOCI | $-587.0K | $-532.0K | $-583.0K | $-612.0K | $-805.0K | $-451.0K | $-228.0K | $-520.0K | $-627.0K | $-563.0K | $-348.0K | $-525.0K | $-795.0K | $-406.0K | $-493.0K | $-335.0K | |
| Stockholders' Equity | $107M | $111M | $114M | $120M | $132M | $145M | $169M | $176M | $195M | $206M | $226M | $234M | $297M | $311M | $364M | $411M | |
| Liabilities + Equity | $198M | $200M | $204M | $212M | $231M | $237M | $264M | $273M | $294M | $306M | $326M | $340M | $408M | $427M | $482M | $533M | |
| Shares Outstanding | 6,781,976 | 6,781,976 | 6,781,976 | 6,781,976 | 6,750,716 | 6,558,927 | 6,525,887 | 6,525,266 | 6,503,913 | 6,503,913 | 6,503,913 | 130,079,097 | 130,079,097 | 130,079,097 | 6,503,913 | 129,753,672 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $248.0K | $12.0K | $12.0K | $12.0K | $12.0K | $498.0K | $741.0K | $901.0K | $975.0K | $993.0K | $1M | $953.0K | $991.0K | $2M | $2M | $2M | |
| Stock-based Comp | $1M | $985.0K | $2M | $2M | $2M | $3M | $5M | $4M | $4M | $5M | $5M | $5M | $4M | $5M | $7M | $8M | |
| Other Non-cash | · | $2M | · | · | · | $20M | · | · | · | $4M | · | · | · | $16M | · | · | |
| Operating Cash Flow | $-5M | $-1M | $-7M | $-11M | $-15M | $-4M | $-11M | $-20M | $-11M | $-14M | $-13M | $-14M | $-20M | $-35M | $-37M | $-41M | |
| CapEx | · | · | · | · | · | · | · | $0 | $0 | $0 | $58.0K | $5M | $7M | $8M | $13M | $25M | |
| Investing Cash Flow | $5M | $-317.0K | $8M | $8M | $-400.0K | $10M | $13M | $20M | $12M | $9M | $14M | $2M | $10M | $15M | $33M | $25M | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $0 | $0 | $0 | $378.0K | $7M | $232.0K | $2M | $159.0K | $0 | $0 | $0 | $-587.0K | $4M | $4M | $6M | $15M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-14M | · | · | · | $-43M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | $-44M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -2.0% | -1.9% | · | -5.6% | -8.2% | -10.4% | · | -7.5% | -4.2% | -6.6% | · | -15.4% | -3.8% | -11.5% | · | -9.5% | |
| ROE | -3.6% | -3.3% | · | -9.2% | -13.1% | -16.1% | · | -11.2% | -6.1% | -9.4% | · | -20.9% | -4.9% | -13.9% | · | -11.1% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | · | -28.5% | -7.1% | -18.8% | · | -13.7% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 21.7 | 39.9 | · | 34.5 | 15.0 | 30.3 | · | 12.9 | 15.1 | 14.2 | · | 14.5 | 12.0 | 9.0 | · | 7.5 | |
| Quick Ratio | 1.7 | 1.1 | · | 1.0 | 0.6 | 2.1 | · | 0.6 | 0.7 | 0.5 | · | 13.6 | 11.0 | 8.4 | · | 7.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -12.1 | · | -33.3 | -35.6 | -91.9 | · | -70.2 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $15.83 | $16.32 | · | $17.76 | $19.50 | $22.09 | · | $27.02 | $29.98 | $31.65 | · | $1.80 | $2.28 | $2.39 | · | $3.16 | |
| Cash Flow / Share | · | $-0.20 | · | · | · | $-0.64 | · | · | · | $-2.21 | · | · | · | $-0.27 | · | · | |
| Cash / Share | $0.82 | $0.74 | · | $0.86 | $1.14 | $2.34 | · | $1.02 | $1.04 | $0.84 | · | $0.07 | $0.17 | $0.21 | · | $0.32 | |
| EPS (TTM) | $-4.39 | $-7.00 | · | $-11.39 | $-12.92 | $-11.97 | · | $-11.56 | $-18.39 | $-18.97 | · | $-55.16 | $-45.22 | $-42.81 | · | $-1.53 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-30M | $-47M | · | $-75M | $-85M | $-78M | · | $-75M | $-120M | $-123M | · | $-197M | $-186M | $-226M | · | $-225M | |
| Market Cap | $52M | $56M | · | $121M | $141M | $114M | · | $439M | $67M | $70M | · | $1.11B | $1.43B | $1.72B | · | $12.56B | |
| P/E | -1.8 | -1.2 | · | -1.6 | -1.6 | -1.5 | · | -5.8 | -0.6 | -0.6 | · | -0.2 | -0.2 | -0.3 | · | -63.3 | |
| P/B | 0.5 | 0.5 | · | 1.0 | 1.1 | 0.8 | · | 2.5 | 0.3 | 0.3 | · | 4.8 | 4.8 | 5.5 | · | 30.6 | |
| P / Tangible Book | 0.5 | 0.5 | · | 1.0 | 1.1 | 0.8 | · | 2.5 | 0.3 | 0.3 | · | 4.8 | 4.8 | 5.5 | · | 31.0 | |
| P / Cash Flow | · | -41.8 | · | · | · | -27.1 | · | · | · | -4.9 | · | · | · | -49.6 | · | · | |
| Earnings Yield | -57.1% | -85.0% | · | -63.8% | -62.0% | -69.0% | · | -17.2% | -178.7% | -175.7% | · | -644.4% | -410.3% | -323.8% | · | -1.6% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | · | · | · | · | $0 |
| Net Income | $-71M | $-74M | $-156M | $-223M | $-157M |
| Diluted EPS | $-10.70 | $-11.39 | $-24.00 | $-34.46 | $-1.48 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 39.5 | 15.8 | 15.2 | 8.2 | 11.2 |
| Quick Ratio | 1.4 | 1.1 | 14.2 | 8.0 | 11.0 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | $-56M | $-103M | $-265M | $-180M |
Institutional owners (13F) 31 filers · $35.2M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
31
Value held
$35.2M
New positions
5
Exited positions
10
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 5 (-5 vs prior Q) | 10 (+5 vs prior Q) | 5 (+1 vs prior Q) | 8 (0 vs prior Q) | -394K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Curative Ventures V LLC | $14,603,341 | 1,899,004 | 41.45% | Shares |
| BML Capital Management, LLC | $4,964,664 | 645,600 | 14.09% | Shares |
| CPMG Inc | $3,385,997 | 410,922 | 9.61% | Shares |
| Vivo Capital, LLC | $2,251,194 | 292,743 | 6.39% | Shares |
| VANGUARD GROUP INC | $2,101,660 | 191,060 | 5.97% | Shares |
| UBS Group AG | $1,364,383 | 177,423 | 3.87% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $1,259,145 | 163,738 | 3.57% | Shares |
| MILLENNIUM MANAGEMENT LLC | $1,034,882 | 134,575 | 2.94% | Shares |
| Kalehua Capital Management LLC | $765,924 | 99,600 | 2.17% | Shares |
| BlackRock, Inc. | $426,826 | 55,504 | 1.21% | Shares |
| AlphaQuest LLC | $410,069 | 37,279 | 1.16% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $386,807 | 50,300 | 1.10% | Shares |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $385,000 | 50,000 | 1.09% | Shares |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $331,062 | 43,051 | 0.94% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $324,923 | 42,234 | 0.92% | Shares |
| LPL Financial LLC | $246,653 | 32,075 | 0.70% | Shares |
| CITADEL ADVISORS LLC | $235,614 | 30,639 | 0.67% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $175,124 | 22,773 | 0.50% | Shares |
| STATE STREET CORP | $135,306 | 17,595 | 0.38% | Shares |
| Americana Partners, LLC | $124,393 | 16,176 | 0.35% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $121,129 | 15,761 | 0.34% | Shares |
| MORGAN STANLEY | $91,773 | 11,934 | 0.26% | Shares |
| Pinpoint Asset Management Ltd | $88,432 | 5,094 | 0.25% | Shares |
| Vanguard Global Advisers, LLC | $11,304 | 1,470 | 0.03% | Shares |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $4,230 | 550 | 0.01% | Shares |
| Lindbrook Capital, LLC | $1,180 | 68 | 0.00% | Shares |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $961 | 125 | 0.00% | Shares |
| CITIGROUP INC | $677 | 88 | 0.00% | Shares |
| Tower Research Capital LLC (TRC) | $246 | 32 | 0.00% | Shares |
| BARCLAYS PLC | $223 | 29 | 0.00% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $54 | 7 | 0.00% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Curative Ventures V LLC, CV-Immetacyte Manager LP, CV-Immetacyte Ultimate Manager LLC, SB2A LP, SB2A Management LLC, Bronson Crouch, Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power CVV 0 37,980,073 0 37,980,073 CV-Immetacyte Manager 0 37,980,073 0 37,980,073 Ultimate Manager 0 37,980,073 0 37,980,073 SB2A 0 40,380,072 0 40,380,072 SB2A Manager 0 40, Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power CVV 0 1,899,003 0 1,899,003 CV-Immetacyte Manager 0 1,899,003 0 1,899,003 Ultimate Manager 0 1,899,003 0 1,899,003 SB2A 0 2,019,002 0 2,019,002 SB2A Manager 0 2,019,002 ×2 filings | Oct. 22, 2024 | · | Initial filing | · | SEC |
| CPMG, INC., R. KENT MCGAUGHY, JR. | April 1, 2021 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 13 insiders · 6 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Bronson Crouch | CEO and Chairman | April 25, 2025 A | 37,980,073 | 0 | 0 | $0 |
| Sandeep Laumas | CFO and CBO | Sept. 10, 2025 M | 0 | 0 | 0 | $0 |
| Timothy L. Moore | Chief Operating Officer | Sept. 6, 2022 A | · | 0 | 0 | $0 |
| Sumita Ray | Chief Legal and Admin Officer | Jan. 18, 2023 A | · | 0 | 0 | $0 |
| Vijay Chiruvolu | Chief Technical Officer | May 20, 2022 A | · | 0 | 0 | $0 |
| Zachary Roberts | Chief Medical Officer | March 4, 2022 A | · | 0 | 0 | $0 |
| George Matcham | Director | June 11, 2026 A | · | 0 | 0 | $0 |
| Gwendolyn Binder | Director | June 11, 2026 A | · | 0 | 0 | $0 |
| Neil W Gibson | Director | June 11, 2026 A | · | 0 | 0 | $0 |
| Kent R Mcgaughy Jr | Director | June 11, 2026 A | 8,218,467 | 0 | 0 | $0 |
| Jack Nielsen | Director | June 14, 2023 A | 12,486,787 | 0 | 0 | $0 |
| Nimish P Shah | Director | March 23, 2021 C | 19,620 | 0 | 0 | $0 |
| Curative Ventures V LLC | 10% owner | March 23, 2021 C | 37,980,073 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 6 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.01% | 12,764 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.00% | 6,653 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 1,000 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 41,589 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 118,992 SH | Aug. 19, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.00% | 1,385 NS | July 31, 2026 | N-PORT |
TIL Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$7.00
-3.0%
2 28.6%
Strong Buy
3 42.9%
Buy
2 28.6%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-09-27Mean target $7.00 -3.0%
Low$7.00
Mean$7.00
High$7.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 13, 2026